Freshpet reported solid performance in Q3 2025 with 14% revenue growth and significant net income driven by a $77.9M tax benefit. The company achieved positive free cash flow ahead of schedule and saw a notable increase in adjusted EBITDA.
Net sales rose 14% YoY to $288.8M, driven by volume growth and favorable price/mix.
Net income surged to $101.7M due to a $77.9M deferred tax benefit.
Adjusted EBITDA reached $54.6M, up from $43.5M the previous year.
Freshpet achieved positive free cash flow ahead of schedule and expects to remain FCF positive for FY2025.
Freshpet revised full-year 2025 guidance to the lower end of previous ranges, maintaining financial discipline while projecting full-year positive free cash flow.